United States · 
Who invested in Zentalis Pharmaceuticals?
Zentalis Pharmaceuticals's investors include Perceptive Advisors, Redmile Group and Viking Global.
United States · Funded startup
Who invested in Zentalis Pharmaceuticals
Funding summaryUpdated 26 Oct 2026
$236Mraised across 1 round since 2023, from 1 source
- Latest round
- Round, $236MJun 2023
- Investors
- 3
The rounds
- Jun 2023
Founders and team
From Zentalis Pharmaceuticals's own website: 8 on the team.
- Julie EastlandChief Executive Officer and Director
- Rajesh IsraniExecutive Vice President, Regulatory Affairs & Medical Writing
- Sarah KellySenior Vice President, Commercial Strategy
- Susan SaffleSenior Vice President, Information Technology
- Haibo WangChief Business Officer
- James BucherChief Legal Officer and Corporate Secretary
- Wendy ChangChief People Officer
- Scott MyersChairperson
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Zentalis Pharmaceuticals
How much has Zentalis Pharmaceuticals raised?
Zentalis Pharmaceuticals has raised $236M across 1 round since 2023.
When did Zentalis Pharmaceuticals last raise?
Zentalis Pharmaceuticals's most recent round was an Undisclosed round of $236M in Jun 2023.
What was Zentalis Pharmaceuticals's biggest round?
Its most recent round, $236M in Jun 2023, is also its largest on record.
Who backed Zentalis Pharmaceuticals first?
Zentalis Pharmaceuticals's first round on record, in Jun 2023, was backed by Perceptive Advisors, Redmile Group and Viking Global.
What stage is Zentalis Pharmaceuticals at?
Zentalis Pharmaceuticals's latest named round is an Undisclosed round, in Jun 2023.
Where is Zentalis Pharmaceuticals based?
Zentalis Pharmaceuticals is based in the United States.
Companies like Zentalis Pharmaceuticals
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.